Dr. John R. Bailey, MD
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 37
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,059
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
NC license 35578 -
Internal Medicine Physician
NC license 35578 -
Interventional Cardiology Physician
NC license 35578
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Novant Health Presbyterian Medical Center Charlotte, NC
- Atrium Health Pineville Charlotte, NC
- Novant Health Matthews Medical Center Matthews, NC
- Novant Health Huntersville Medical Center Huntersville, NC
- Novant Health Mint Hill Medical Center Charlotte, NC
Medical groups
- Novant Health Medical Group, LLC (2,430 clinicians)
- The Presbyterian Hospital (414 clinicians)
- Novant Health Matthews Medical Center LLC (70 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,059
- Services billed
- 3,330
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,292 | 470 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 711 | 452 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 574 | 203 |
| Programming of dual lead pacemaker system | 200 | 128 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 147 | 27 |
| Established patient office or other outpatient visit, 30-39 minutes | 119 | 108 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | 80 |
| New patient office or other outpatient visit, 45-59 minutes | 77 | 77 |
| Programming of dual lead implantable defibrillator system | 58 | 47 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 56 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Charlotte, NC | 178 |
| Metoprolol Succinate Other prescribers in Charlotte, NC | 111 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Charlotte, NC | 82 |
| Flecainide Acetate Other prescribers in Charlotte, NC | 63 |
| Amiodarone Hcl Other prescribers in Charlotte, NC | 55 |
| Xarelto (rivaroxaban) Other prescribers in Charlotte, NC | 55 |
| Cephalexin Other prescribers in Charlotte, NC | 51 |
| Carvedilol Other prescribers in Charlotte, NC | 41 |
| Sotalol (sotalol hcl) Other prescribers in Charlotte, NC | 32 |
| Warfarin Sodium Other prescribers in Charlotte, NC | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 18 payments worth $356 in total to this clinician.
| Abbott Laboratories | $207 |
|---|---|
| Medtronic, Inc. | $81.10 |
| Novartis Pharmaceuticals Corporation | $29.24 |
| Cvrx, Inc. | $24.42 |
| Boston Scientific Corporation | $13.57 |
| Food and Beverage | $356 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,335 in research payments for these studies, mostly to the institutions running them.
- ZOLL Respicardia, Inc. Registry Study
Zoll Respicardia, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.